-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D7y8gbeO1sdWLPU9dA2guFgUqSjC56+7r5ZXpZhu8TAny8QsQxmcEmhtMEm/SDBj RP64VX4rZf8ys6Zcgv5zww== 0001164150-05-000148.txt : 20050516 0001164150-05-000148.hdr.sgml : 20050516 20050516151809 ACCESSION NUMBER: 0001164150-05-000148 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050331 FILED AS OF DATE: 20050516 DATE AS OF CHANGE: 20050516 EFFECTIVENESS DATE: 20050516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO SOLUTIONS INTERNATIONAL INC CENTRAL INDEX KEY: 0000842013 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 850368333 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 033-25126-D FILM NUMBER: 05833825 BUSINESS ADDRESS: STREET 1: 1281 SW 28TH AVENUE CITY: BOYNTON BEACH STATE: FL ZIP: 33426 BUSINESS PHONE: 5614367064 MAIL ADDRESS: STREET 1: 1281 SW 28TH AVENUE CITY: BOYNTON BEACH STATE: FL ZIP: 33426 FORMER COMPANY: FORMER CONFORMED NAME: SEPTIMA ENTERPRISES INC DATE OF NAME CHANGE: 19920703 NT 10-Q 1 bsii-10qsbnt032005.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING Commission File Number: 33-25126-D (Check One) [_] Form 10-K [_] Form 10-KSB [_] Form 20-F [_] Form 11-K [_] Form 10-Q [_] Form 10-QSB [_] Form N-SAR For Period Ended: March 31, 2005 [_] Transition Report on Form 10-K [_] Transition Report on Form 20-F [_] Transition Report on Form 11-K [_] Transition Report on Form 10-Q [_] Transition Report on Form N-SAR For the Transition Period Ended: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - PART 1 -- REGISTRANT INFORMATION BIO-SOLUTIONS INTERNATIONAL, INC. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Full Name of Registrant N/A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Former Name if Applicable 1281 SW 28th Avenue - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Address of Principal Executive Office (Street and Number) Boynton Beach, FL 33426 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - City, State and Zip Code PART II -- RULES 12b-25 (b) and (c) If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) [X] (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; [X] (b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K, or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and [_] (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. PART III -- NARRATIVE State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period. Information regarding certain material operations of the Company as well as its financial statements for the Quarterly Report on Form 10-QSB required for the filing could not be made available without unreasonable effort and expense. PART IV -- OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification. Michael Bobrick (561) 436-7064 ------------------------- -------------- ------------------------ (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such reports been filed? If answer is no, identify report(s). [X] Yes [_] No (3) Is it anticipated that any significant change in results or operations from the corresponding period for the last fiscal quarter will be reflected by the earnings statements to be included in the subject report or portion thereof. [_] Yes [X] No If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if separate, state the reasons why a reasonable estimate of the results cannot be made. SIGNATURES BIO-SOLUTIONS INTERNATIONAL, INC. - - - - - - - - - - - - - - - - - - - - - - (Name of Registrant as Specified in Charter) In accordance with Section 13 or 15(d) of the Exchange Act, the registrant has caused this notification to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 16, 2005 By: /s/ Michael Bobrick ------------------------------------------- Name: Michael Bobrick Title: President, Chief Executive Officer and Sole Director -----END PRIVACY-ENHANCED MESSAGE-----